-transparent.png){kind=logo}
A total of 11 newly synthesized 2-chloroethyl-nitrosoureas and 1 2-fluoroethyl-nitrosourea with short-chain substituents were tested for their cytostatic activity on the L1210 mouse leukemia in comparison to clinically used nitrosoureas. Initial experiments showed advantages of the i.v. route for tumor inoculation. Therefore, the anatomical generalisation of tumor cells after i.v. injection was studied by bio-assay. Tumor cell determinations in different organs were 10 to 100 times higher compared with i.p. implantation. Of the new compounds 10 showed marked cytostatic activity in this tumor model by producing cures, and 5 of them must be considered as superior to BCNU, the most commonly used nitrosourea.
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
February 1987,
Gan to kagaku ryoho. Cancer & chemotherapy,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
April 1979,
European journal of cancer,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
October 1965,
Cancer chemotherapy reports,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
January 1992,
Cancer immunology, immunotherapy : CII,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
October 1975,
Biomedicine / [publiee pour l'A.A.I.C.I.G.],
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
August 1980,
Gan,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
January 1988,
Neoplasma,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
December 1979,
Cancer research,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
February 1974,
Journal of medicinal chemistry,
J R Schmid, and
H H Fiebig, and
G Eisenbrand, and
G W Löhr
January 1990,
Neoplasma,
